Related Experiment Video
Updated: Aug 6, 2026

Mitochondrial Transfer Via Tunneling Nanotubes Between Mesenchymal Stem Cells and Retinal Pigment Epithelium In Vitro
Published on: October 4, 2024
Leveraging Mitochondria-Endoplasmic Reticulum Functional Interplay With an On-Demand Nanoparticle to Boost
Han Chen1,2, Haijing Qu1,2, Yuqing Pan1
1Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, China.
This study introduces a novel nanoparticle system that enhances STING activation by releasing mitochondrial DNA and inducing ER stress. This approach boosts antitumor immunity, suppressing tumor growth and recurrence in preclinical models.
Area of Science:
- Immunology
- Nanotechnology
- Cancer Biology
Background:
- Endogenous STING activation by mitochondrial DNA (mtDNA) is a potential cancer immunotherapy strategy.
- Current limitations include weak and transient signaling, hindering robust STING clustering and efficacy.
- Mitochondrial-ER functional interplay is key to modulating STING signaling.
Purpose of the Study:
- To develop an on-demand nanoparticle system to enhance STING activation for cancer immunotherapy.
- To harness mitochondrial-ER interplay by inducing mtDNA release and ER stress.
- To improve STING-TBK1 assembly and downstream signaling for potent antitumor responses.
Main Methods:
- Developed a nanoparticle system for concurrent mtDNA release and ER stress induction.
- Utilized nanoparticles for spatially controlled co-delivery of immunotherapy agents.
- Assessed STING, TBK1, and IRF3 phosphorylation levels.
- Evaluated CD8+, CD4+ T cell infiltration and regulatory T cell (Treg) populations in vivo.
- Tested efficacy in mouse models of breast and colon cancer.
Main Results:
- The nanoparticle system significantly increased STING, TBK1, and IRF3 phosphorylation compared to PBS.
- Performance surpassed the commercial STING agonist MSA-2.
- Achieved potent enhancement of innate and adaptive antitumor immunity in vivo.
- Demonstrated significant increases in CD8+ and CD4+ T cell infiltration and reduction in Tregs.
- Successfully suppressed tumor progression, metastasis, and recurrence in preclinical models.
Conclusions:
- The developed on-demand nanoparticle system effectively enhances STING-based immunotherapy.
- This strategy integrates controlled drug release with organelle-level immune modulation.
- The approach shows significant promise for improving cancer treatment outcomes by boosting antitumor immunity.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Tumor Immunotherapy
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondria
The Inner Mitochondrial Membrane
Animal Mitochondrial Genetics

